Hutchinson-Gilford Progeria Syndrome (HGPS)
relevant aspects of a rare syndrome diagnosed in a Brazilian child
DOI:
https://doi.org/10.5935/2525-5711.20160009Keywords:
cell aging, oral manifestations, progeriaAbstract
Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare genetic condition characterized by premature aging and it’s about one case for every four to eight million people. Children affected usually have premature death due to cardiovascular problems. The gene that causes progeria was recently discovered and it has attracted the interest of the scientific community worldwide not only by the possibility of cure of this genetic pathology but also because of the possibility to retard or to minimize the effects of premature aging caused by the disease in human beings. Among the oral and facial findings is remarkable the delay in tooth eruption, the micrognathia and the disproportion between the skull and face. Dental treatment is directed to preventive aspects and strict supervision of oral conditions in order to minimize the need for more invasive treatments. The authors highlight the most relevant aspects related to that syndrome, emphasizing the important aspects to all the oral and maxillofacial surgeons, reporting a case of progeria in a five-year old Brazilian child.
References
Hutchinson J. Case of congenital absence of hair, with atrophic condition of the skin and it appendages, in a boy whose mother had been almost wholly bald from alopecia areata from the age of six. Lancet I. 1886;923.
Gilford H. Ateliosis and progeria: continuous youth and premature old age. Brit Med J. 1904;2:914-918.
Pollex RL, Hegele RA. Mini-Review. Hutchinson-Gilford syndrome. Clin. Genet. 2004;66(5):375-381.
Hennekam RCM. Hutchinson-Gilford progeria syndrome: review of the fhenotype. Am J Med Genet. 2006;140(23):2603-2624. DOI: http://dx.doi.org/10.1002/ajmg.a.31346
Czoca AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet. 2004;41(4):304-308.
Eriksson M,Brown WT,Gordon LB,Glyn MW,Singer J,Scott L.et al. Recurrent de novo points mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423(6937);293-298.
Cappel BC, Olive M, Erdos MR, Cao K, Faddah DA,Tavarez UL et al. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. PNAS. 2008;105(41):15902-15907. DOI: http://dx.doi.org/10.1073/pnas.0807840105
Columbaro M, Cappani C, Mattioli E, Novelli G, Parnaik VK, Squarzoni S et al. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. Cell Mol Life Sci. 2005;62(22):2669-2678. DOI: http://dx.doi.org/10.1007/s00018-005-5318-6
Meta M,Yang SH, Bergo MO, Fong LG,Young SG. Protein farnesyltransferase inhibitors and progeria. Trends Mol Med. 2006;12(10):480-487. DOI: http://dx.doi.org/10.1016/j.molmed.2006.08.006
Sagelius H, Rosengardten Y, Schmidt E, Sonnabend C, Eriksson M. Reversible phenotype in a mouse model of Hutchinson-Gilford progeria syndrome. J Med Genet. 2008;45(12):794-801. DOI: http://dx.doi.org/10.1136/jmg.2008.060772
Yang SH, Andres DA, Spielmann P, Young SG, Fong LG. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J Clin Invest. 2008;118(10):3291-3300. PMID: 18769635 DOI: http://dx.doi.org/10.1172/JCI35876
Lembke CG,Marcondes E, Rotenberg LKB, Takahashi RF, Villela VH. Progéria. Estudo biopsicossocial de um caso. Pediat.1981;3(4):367-380.
Maloney WJ. Hutchinson-Gilforg progeria syndrome: Its presentation in F. Scott Fitzgerald's short story "The curious case of Benjamin Button" and its oral manifestations. Dent Res. 2009;88(10):873-876. PMID: 19783794
Batstone MD,Macleod WG. Oral and maxillofacial surgical considerations for a case of Hutchinson-Gilford progeria. Int J Pediat Dent. 2002;12(6):429-432. DOI: http://dx.doi.org/10.1046/j.1365-263X.2002.00401.x
Merideth MA,Gordon LB,Clauss S, Sachdev V, Smith AC,Perry MB et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N. Engl. J. Med. 2008;358(6):592-604. PMID: 18256394
Shiraishi I, Shiraishi S, Hirai E, Onouchi Z, Hamaoka K. Fatal pulmonary hypertension associated with an atypical case of Hutchinson-Gilford progeria. Ped Cardiol. 2001;22:530-533. DOI: http://dx.doi.org/10.1007/s002460010292
Shalev SA, Sandre-Giovanolli A, Shani AA, Levy N. An association of Hutchinson-Gilford progeria and malignancy. Am J Med Genet. 2007;143A(16):1821-1826.
Hegele RA. Drawing the line in progeria syndromes. Lancet. 2003;362(9382):416-417. PMID: 12927424 DOI: http://dx.doi.org/10.1016/S0140-6736(03)14097-4
Gordon LB, Harling-Berg CJ, Rothman FG. Meeting Report. Highlights of the 2007 progeria research foundation scientific workshop: progress in translational science. J Gerontol: Biol Scienc. 2008;63A(8):777-787.
Uitto J. Searching for clues to premature aging. Trends Endocrinol Metabol. 2002;13(4):140-141. DOI: http://dx.doi.org/10.1016/S1043-2760(02)00595-7
Viégas J, Souza PLR, Salzano FM. Progeria in twins. J Med Genet. 1974;11(4):384-386. DOI:http://dx.doi.org/10.1136/jmg.11.4.384
QX, Zeng LH. Progeria: report of a case and review of the literature. J Oral Pathol Med. 1991;20(2):86-88. DOI: http://dx.doi.org/10.1111/j.1600-0714.1991.tb00895.x
Rodrigues GLP, Tâ;mega IE, Duque G, Dias Neto VS. Severe bone changes in a case of Hutchinson-Gilford syndrome. An Genet. 2002;45(3):151-155.
Gordon LB, McCarten KM, Giobbie-Hurder A, Machan JT, Campbell MA,Berns SD et al. Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development. Pediatrics. 2007;120:824-833. DOI: http://dx.doi.org/10.1542/peds.2007-1357
Domingo DL, Trujillo MI, Council SE, Merideth MA, Gordon LB, Wu T et al. Hutchinson-Gilford progeria syndrome: oral and craniofacial phenotypes. Oral Dis. 2009;15(3):187-195. DOI: http://dx.doi.org/10.1111/j.1601-0825.2009.01521.x
